Review



a ctm  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress a ctm
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    A Ctm, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a ctm/product/MedChemExpress
    Average 93 stars, based on 5 article reviews
    a ctm - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer"

    Article Title: Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer

    Journal: Science Advances

    doi: 10.1126/sciadv.ady5324

    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + CTM, but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an AR-V7 PROTAC. Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Figure Legend Snippet: ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + CTM, but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an AR-V7 PROTAC. Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.

    Techniques Used: Immunofluorescence, Staining, Fluorescence, Expressing, In Vivo, Injection, CCK-8 Assay, Reverse Transcription Polymerase Chain Reaction, Two Tailed Test

    ( A ) OCR analysis of C4-2 cells treated with 10 or 20 mM lactate and PBS, followed by mitochondrial stress tests using oligomycin, carbonyl cyanide p -trifluoromethoxyphenylhydrazone (FCCP), and rotenone. Quantification of maximum and basal respiration is shown on the right ( n = 5). ( B ) CCK-8 assay showing cell proliferation of C4-2 cells treated with DMSO or rotenone under continuous ENZ treatment. ( C ) RT-PCR and Western blot analysis of AR and AR-V7 expression in C4-2 cells cultured with A + CTM and treated with DMSO or rotenone. ( D ) Western blot analysis showing pan-lactylation (Pan-Lacyl), pan-ubiquitination (Pan-Ubi), pan-phosphorylation (Pan-Pho), and pan-acetylation (Pan-Ace) in C4-2 cells treated with 1640 or A + CTM. ( E ) Western blot analysis of Pan-Lac in C4-2 cells treated with NALA or DMSO. ( F ) Heatmap and KEGG pathway enrichment analysis of differentially lactylated proteins in C4-2 cells treated with A + CTM compared to A − CTM ( n = 3). ( G ) Volcano plot showing the differentially lactylated proteins in C-2 cells treated with A + CTM compared to A − CTM. ( H ) CCK-8 assay showing cell proliferation of C4-2 cells treated with siSNRPA or siNC, NALA or DMSO, and ENZ. ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2, LNCaP, and VCaP cells treated with siSNRPA and siNC. Data represent the means ± SD. Statistical significance was determined by a two-way ANOVA followed by a multiple comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.
    Figure Legend Snippet: ( A ) OCR analysis of C4-2 cells treated with 10 or 20 mM lactate and PBS, followed by mitochondrial stress tests using oligomycin, carbonyl cyanide p -trifluoromethoxyphenylhydrazone (FCCP), and rotenone. Quantification of maximum and basal respiration is shown on the right ( n = 5). ( B ) CCK-8 assay showing cell proliferation of C4-2 cells treated with DMSO or rotenone under continuous ENZ treatment. ( C ) RT-PCR and Western blot analysis of AR and AR-V7 expression in C4-2 cells cultured with A + CTM and treated with DMSO or rotenone. ( D ) Western blot analysis showing pan-lactylation (Pan-Lacyl), pan-ubiquitination (Pan-Ubi), pan-phosphorylation (Pan-Pho), and pan-acetylation (Pan-Ace) in C4-2 cells treated with 1640 or A + CTM. ( E ) Western blot analysis of Pan-Lac in C4-2 cells treated with NALA or DMSO. ( F ) Heatmap and KEGG pathway enrichment analysis of differentially lactylated proteins in C4-2 cells treated with A + CTM compared to A − CTM ( n = 3). ( G ) Volcano plot showing the differentially lactylated proteins in C-2 cells treated with A + CTM compared to A − CTM. ( H ) CCK-8 assay showing cell proliferation of C4-2 cells treated with siSNRPA or siNC, NALA or DMSO, and ENZ. ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2, LNCaP, and VCaP cells treated with siSNRPA and siNC. Data represent the means ± SD. Statistical significance was determined by a two-way ANOVA followed by a multiple comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Techniques Used: CCK-8 Assay, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Cell Culture, Ubiquitin Proteomics, Phospho-proteomics

    ( A to C ) AR-V7 expression and ENZ resistance after heat inactivation, proteinase K (PK), DNase, or ribonuclease (RNase) treatment with A + CTM in C4-2 cells. ( D ) Heatmap showing untargeted metabolomic profiling of A + CTM and A − CTM ( n = 6 for each group). ( E ) KEGG pathway analysis of differentially abundant metabolites in A + CTM versus A − CTM. ( F ) Principal components analysis (PCA) of targeted metabolomics data from A + CTM and A − CTM ( n = 6 for each group). ( G ) Heatmap of key metabolites detected in A + CTM and A − CTM. ( H ) Gene set enrichment analysis in A + CAFs. ( I ) Volcano plot of metabolomic data comparing A + CAFs and A − CAFs ( n = 6 for each group). ( J ) Quantification of relative lactate levels in the conditioned medium from A + CAFs, A − CAFs, C4-2 cells, and controls. h, hours. ( K ) Colony formation assays of C4-2 cells treated with DMSO or lactate (LAC) with and without ENZ treatment ( n = 3). ( L ) AR and AR-V7 expression in C4-2 cells treated with DMSO or lactate. ( M ) Tumor growth of C4-2 cells injected into castrated NSG mice treated with PBS or lactate with or without ENZ ( n = 5 for each group). ( N ) Images of PDOs treated with lactate or DMSO with or without ENZ. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( O and P ) Schematic and colony formation assay of medium change experiments in the coculture system of A + CAFs and C4-2 cells with or without ENZ. The medium was changed every 24 or 72 hours to modulate lactate concentration within the medium ( n = 3). Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test and two-way ANOVA followed by a multiple comparisons test. ** P < 0.01, *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.
    Figure Legend Snippet: ( A to C ) AR-V7 expression and ENZ resistance after heat inactivation, proteinase K (PK), DNase, or ribonuclease (RNase) treatment with A + CTM in C4-2 cells. ( D ) Heatmap showing untargeted metabolomic profiling of A + CTM and A − CTM ( n = 6 for each group). ( E ) KEGG pathway analysis of differentially abundant metabolites in A + CTM versus A − CTM. ( F ) Principal components analysis (PCA) of targeted metabolomics data from A + CTM and A − CTM ( n = 6 for each group). ( G ) Heatmap of key metabolites detected in A + CTM and A − CTM. ( H ) Gene set enrichment analysis in A + CAFs. ( I ) Volcano plot of metabolomic data comparing A + CAFs and A − CAFs ( n = 6 for each group). ( J ) Quantification of relative lactate levels in the conditioned medium from A + CAFs, A − CAFs, C4-2 cells, and controls. h, hours. ( K ) Colony formation assays of C4-2 cells treated with DMSO or lactate (LAC) with and without ENZ treatment ( n = 3). ( L ) AR and AR-V7 expression in C4-2 cells treated with DMSO or lactate. ( M ) Tumor growth of C4-2 cells injected into castrated NSG mice treated with PBS or lactate with or without ENZ ( n = 5 for each group). ( N ) Images of PDOs treated with lactate or DMSO with or without ENZ. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( O and P ) Schematic and colony formation assay of medium change experiments in the coculture system of A + CAFs and C4-2 cells with or without ENZ. The medium was changed every 24 or 72 hours to modulate lactate concentration within the medium ( n = 3). Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test and two-way ANOVA followed by a multiple comparisons test. ** P < 0.01, *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Techniques Used: Expressing, Metabolomic, Injection, Colony Assay, Concentration Assay, Two Tailed Test



    Similar Products

    94
    Agilent technologies glyko sialidase ctm
    Glyko Sialidase Ctm, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glyko sialidase ctm/product/Agilent technologies
    Average 94 stars, based on 1 article reviews
    glyko sialidase ctm - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    MedChemExpress a ctm
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    A Ctm, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a ctm/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    a ctm - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Rogue Research inc ctms device
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Ctms Device, supplied by Rogue Research inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctms device/product/Rogue Research inc
    Average 90 stars, based on 1 article reviews
    ctms device - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    97
    Copan Diagnostics noble bio ctm
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Noble Bio Ctm, supplied by Copan Diagnostics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/noble bio ctm/product/Copan Diagnostics
    Average 97 stars, based on 1 article reviews
    noble bio ctm - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    Dovetail Genomics dovetailtm omni-ctm kit
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Dovetailtm Omni Ctm Kit, supplied by Dovetail Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dovetailtm omni-ctm kit/product/Dovetail Genomics
    Average 90 stars, based on 1 article reviews
    dovetailtm omni-ctm kit - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Janssen chemical transport models (ctm)
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Chemical Transport Models (Ctm), supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemical transport models (ctm)/product/Janssen
    Average 90 stars, based on 1 article reviews
    chemical transport models (ctm) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Inserm Transfert ctm inserm u1231
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Ctm Inserm U1231, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctm inserm u1231/product/Inserm Transfert
    Average 90 stars, based on 1 article reviews
    ctm inserm u1231 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Aurion bsa-ctm
    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + <t>CTM,</t> but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an <t>AR-V7</t> <t>PROTAC.</t> Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.
    Bsa Ctm, supplied by Aurion, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsa-ctm/product/Aurion
    Average 90 stars, based on 1 article reviews
    bsa-ctm - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + CTM, but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an AR-V7 PROTAC. Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.

    Journal: Science Advances

    Article Title: Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer

    doi: 10.1126/sciadv.ady5324

    Figure Lengend Snippet: ( A ) Immunofluorescence staining and fluorescence intensity quantification of A − CAFs and A + CAFs showing the expression of APCDD1 (green) and COL1A1 (red). Scale bars: 50 μm. ( B and C ) Schematic of the Boyden chamber coculture system and colony formation assays used to indirectly coculture C4-2 and LNCaP cells with A + CAFs or A − CAFs with or without ENZ treatment. Quantification of colonies is shown on the right ( n = 3). ( D ) Images of PDOs cocultured with A + CAFs or A − CAFs, with and without ENZ treatment. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( E ) Schematic of in vivo experiments. C4-2 cells were co-injected with A + CAFs or A − CAFs into castrated NSG mice, followed by ENZ treatment. Tumor growth analysis confirms that A + CAFs significantly enhanced tumor growth under ENZ treatment ( n = 5 for each group). ( F ) CCK-8 assay showing increased cell viability in C4-2 cells treated with A + CTM, but not A − CTM, under ENZ treatment. ( G and H ) Gene ontology enrichment and gene set enrichment analysis of differentially expressed genes in C4-2 cells treated with A + CTM versus A − CTM, highlighting RNA splicing–related pathways ( n = 5 for each group). ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2 cells treated with A + CTM, showing an increase in AR-V7 levels. ( J ) CCK-8 assay showing the reversal of A + CTM-induced ENZ resistance in C4-2 cells treated with an AR-V7 PROTAC. Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test [(B) to (D)] and two-way ANOVA [(E), (F), and (J)] followed by a multiple comparisons test. ** P < 0.01, and *** P < 0.001. ns, not significant.

    Article Snippet: C4-2 and LNCaP cells were plated in 96-well plates at a density of 3000 cells per well and treated with A + CTM, A − CTM, NALA (L7022, Sigma-Aldrich), l -lactate (L1750, Sigma-Aldrich), PROTAC AR-V7 degrader-1 (HY-145479, MedChem Express), or ENZ.

    Techniques: Immunofluorescence, Staining, Fluorescence, Expressing, In Vivo, Injection, CCK-8 Assay, Reverse Transcription Polymerase Chain Reaction, Two Tailed Test

    ( A ) OCR analysis of C4-2 cells treated with 10 or 20 mM lactate and PBS, followed by mitochondrial stress tests using oligomycin, carbonyl cyanide p -trifluoromethoxyphenylhydrazone (FCCP), and rotenone. Quantification of maximum and basal respiration is shown on the right ( n = 5). ( B ) CCK-8 assay showing cell proliferation of C4-2 cells treated with DMSO or rotenone under continuous ENZ treatment. ( C ) RT-PCR and Western blot analysis of AR and AR-V7 expression in C4-2 cells cultured with A + CTM and treated with DMSO or rotenone. ( D ) Western blot analysis showing pan-lactylation (Pan-Lacyl), pan-ubiquitination (Pan-Ubi), pan-phosphorylation (Pan-Pho), and pan-acetylation (Pan-Ace) in C4-2 cells treated with 1640 or A + CTM. ( E ) Western blot analysis of Pan-Lac in C4-2 cells treated with NALA or DMSO. ( F ) Heatmap and KEGG pathway enrichment analysis of differentially lactylated proteins in C4-2 cells treated with A + CTM compared to A − CTM ( n = 3). ( G ) Volcano plot showing the differentially lactylated proteins in C-2 cells treated with A + CTM compared to A − CTM. ( H ) CCK-8 assay showing cell proliferation of C4-2 cells treated with siSNRPA or siNC, NALA or DMSO, and ENZ. ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2, LNCaP, and VCaP cells treated with siSNRPA and siNC. Data represent the means ± SD. Statistical significance was determined by a two-way ANOVA followed by a multiple comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Journal: Science Advances

    Article Title: Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer

    doi: 10.1126/sciadv.ady5324

    Figure Lengend Snippet: ( A ) OCR analysis of C4-2 cells treated with 10 or 20 mM lactate and PBS, followed by mitochondrial stress tests using oligomycin, carbonyl cyanide p -trifluoromethoxyphenylhydrazone (FCCP), and rotenone. Quantification of maximum and basal respiration is shown on the right ( n = 5). ( B ) CCK-8 assay showing cell proliferation of C4-2 cells treated with DMSO or rotenone under continuous ENZ treatment. ( C ) RT-PCR and Western blot analysis of AR and AR-V7 expression in C4-2 cells cultured with A + CTM and treated with DMSO or rotenone. ( D ) Western blot analysis showing pan-lactylation (Pan-Lacyl), pan-ubiquitination (Pan-Ubi), pan-phosphorylation (Pan-Pho), and pan-acetylation (Pan-Ace) in C4-2 cells treated with 1640 or A + CTM. ( E ) Western blot analysis of Pan-Lac in C4-2 cells treated with NALA or DMSO. ( F ) Heatmap and KEGG pathway enrichment analysis of differentially lactylated proteins in C4-2 cells treated with A + CTM compared to A − CTM ( n = 3). ( G ) Volcano plot showing the differentially lactylated proteins in C-2 cells treated with A + CTM compared to A − CTM. ( H ) CCK-8 assay showing cell proliferation of C4-2 cells treated with siSNRPA or siNC, NALA or DMSO, and ENZ. ( I ) RT-PCR analysis of AR and AR-V7 expression in C4-2, LNCaP, and VCaP cells treated with siSNRPA and siNC. Data represent the means ± SD. Statistical significance was determined by a two-way ANOVA followed by a multiple comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Article Snippet: C4-2 and LNCaP cells were plated in 96-well plates at a density of 3000 cells per well and treated with A + CTM, A − CTM, NALA (L7022, Sigma-Aldrich), l -lactate (L1750, Sigma-Aldrich), PROTAC AR-V7 degrader-1 (HY-145479, MedChem Express), or ENZ.

    Techniques: CCK-8 Assay, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Cell Culture, Ubiquitin Proteomics, Phospho-proteomics

    ( A to C ) AR-V7 expression and ENZ resistance after heat inactivation, proteinase K (PK), DNase, or ribonuclease (RNase) treatment with A + CTM in C4-2 cells. ( D ) Heatmap showing untargeted metabolomic profiling of A + CTM and A − CTM ( n = 6 for each group). ( E ) KEGG pathway analysis of differentially abundant metabolites in A + CTM versus A − CTM. ( F ) Principal components analysis (PCA) of targeted metabolomics data from A + CTM and A − CTM ( n = 6 for each group). ( G ) Heatmap of key metabolites detected in A + CTM and A − CTM. ( H ) Gene set enrichment analysis in A + CAFs. ( I ) Volcano plot of metabolomic data comparing A + CAFs and A − CAFs ( n = 6 for each group). ( J ) Quantification of relative lactate levels in the conditioned medium from A + CAFs, A − CAFs, C4-2 cells, and controls. h, hours. ( K ) Colony formation assays of C4-2 cells treated with DMSO or lactate (LAC) with and without ENZ treatment ( n = 3). ( L ) AR and AR-V7 expression in C4-2 cells treated with DMSO or lactate. ( M ) Tumor growth of C4-2 cells injected into castrated NSG mice treated with PBS or lactate with or without ENZ ( n = 5 for each group). ( N ) Images of PDOs treated with lactate or DMSO with or without ENZ. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( O and P ) Schematic and colony formation assay of medium change experiments in the coculture system of A + CAFs and C4-2 cells with or without ENZ. The medium was changed every 24 or 72 hours to modulate lactate concentration within the medium ( n = 3). Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test and two-way ANOVA followed by a multiple comparisons test. ** P < 0.01, *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Journal: Science Advances

    Article Title: Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer

    doi: 10.1126/sciadv.ady5324

    Figure Lengend Snippet: ( A to C ) AR-V7 expression and ENZ resistance after heat inactivation, proteinase K (PK), DNase, or ribonuclease (RNase) treatment with A + CTM in C4-2 cells. ( D ) Heatmap showing untargeted metabolomic profiling of A + CTM and A − CTM ( n = 6 for each group). ( E ) KEGG pathway analysis of differentially abundant metabolites in A + CTM versus A − CTM. ( F ) Principal components analysis (PCA) of targeted metabolomics data from A + CTM and A − CTM ( n = 6 for each group). ( G ) Heatmap of key metabolites detected in A + CTM and A − CTM. ( H ) Gene set enrichment analysis in A + CAFs. ( I ) Volcano plot of metabolomic data comparing A + CAFs and A − CAFs ( n = 6 for each group). ( J ) Quantification of relative lactate levels in the conditioned medium from A + CAFs, A − CAFs, C4-2 cells, and controls. h, hours. ( K ) Colony formation assays of C4-2 cells treated with DMSO or lactate (LAC) with and without ENZ treatment ( n = 3). ( L ) AR and AR-V7 expression in C4-2 cells treated with DMSO or lactate. ( M ) Tumor growth of C4-2 cells injected into castrated NSG mice treated with PBS or lactate with or without ENZ ( n = 5 for each group). ( N ) Images of PDOs treated with lactate or DMSO with or without ENZ. Quantification of organoid size is shown on the right ( n = 30). Scale bars: 100 μm. ( O and P ) Schematic and colony formation assay of medium change experiments in the coculture system of A + CAFs and C4-2 cells with or without ENZ. The medium was changed every 24 or 72 hours to modulate lactate concentration within the medium ( n = 3). Data represent the means ± SD. Statistical significance was determined by a two-tailed unpaired t test and two-way ANOVA followed by a multiple comparisons test. ** P < 0.01, *** P < 0.001. All experiments were independently replicated three times in the laboratory ( n = 3) to ensure biological reproducibility.

    Article Snippet: C4-2 and LNCaP cells were plated in 96-well plates at a density of 3000 cells per well and treated with A + CTM, A − CTM, NALA (L7022, Sigma-Aldrich), l -lactate (L1750, Sigma-Aldrich), PROTAC AR-V7 degrader-1 (HY-145479, MedChem Express), or ENZ.

    Techniques: Expressing, Metabolomic, Injection, Colony Assay, Concentration Assay, Two Tailed Test